MedPath

Treatment of Nevus Flammeus With Alexandrite Laser

Not Applicable
Completed
Conditions
Nevus Flammeus
Interventions
Procedure: Alexandrite laser
Registration Number
NCT01968681
Lead Sponsor
Bispebjerg Hospital
Brief Summary

Nevus flammeus is a congenital vascular malformation. Nevus flammeus is traditionally treated with pulsed dye lasers (PDL); however, around 20 percent of patients are poor responders and do not get satisfactory results from pulsed dye laser treatments.

Small studies with alexandrite lasers indicate that this may be an alternative treatment for individuals with nevus flammeus. This study assesses the clinical effect and side effects of alexandrite laser treatment for nevus flammeus using different treatment settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • 10 or more years of age
  • Fitzpatrick Skin Type I-III
  • Previously untreated or pulsed dye laser-insufficiently treated nevus flammeus
  • Nevus flammeus size minimum 8 x 2 centimeter within one anatomical region
  • Written and oral informed consent
Exclusion Criteria
  • Known light sensibility toward visible light
  • Tendency to develop hypertrophic scars or keloids
  • Fitzpatrick Skin Type IV-VI
  • Individuals, that are obviously pigmented due to recent sun exposure or sun beds
  • Treatment with systemic retinoids within 6 months
  • Pregnancy and lactation
  • Unwillingness to complete protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Alexandrite laser treatmentAlexandrite laser-
Primary Outcome Measures
NameTimeMethod
Reduction in clinical appearance on a 10-point scale6-8 weeks
Secondary Outcome Measures
NameTimeMethod
Skin reflectance measurement to assess degree of redness6-8 weeks
Skin reflectance to assess degree of pigmentation6-8 weeks

Trial Locations

Locations (1)

Bispebjerg Hospital

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath